• We apologize for the intermittent downtime on the site as we work through some technical difficulties.

FDA grants IND clearance for Find’s Phase I chronic optic neuropathy trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 28, 2024 at 09:22: PM
via The US Food and Drug Administration (FDA) has granted clearance for Find Therapeutics’ investigational new drug (IND) application to commence a Phase I trial of FTX-101, aimed at treating chronic optic neuropathy (CON).

article source
 




Similar threads

cafead
FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial
Replies
0
Views
8
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Replies
0
Views
21
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Indapta’s multiple sclerosis treatment trial
Replies
0
Views
28
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Allay’s trial of post-surgical pain treatment
Replies
0
Views
18
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA grants IND clearance for Spinogenix’s ALS treatment trial
Replies
0
Views
65
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote